Johnson & Johnson JNJ
NYSE JNJ
$261.49 +5.00 (+1.95%)
At close: Oct 9, 2026 · 4:00 PM EDT

Johnson & Johnson (JNJ) Selling, General & Administrative (2009 - 2026)

Updated

Johnson & Johnson (JNJ) recorded Selling, General & Administrative of $6.43 billion in Q2 2026, up 9.2% from $5.89 billion a year earlier and up 6.6% from the prior quarter.

Analysis

Johnson & Johnson (JNJ) Selling, General & Administrative (2009 - 2026) Analysis & Trends

On a TTM basis, Johnson & Johnson's Selling, General & Administrative came in at $25.14 billion as of Jun 28, 2026, up 9.6% year-over-year; for FY2025, it was $23.68 billion, up 3.5% from FY2024.

  • Annual Selling, General & Administrative has increased for three straight years, with a four-year compound annual growth rate of 1.8% (FY2021 to FY2025).
  • Across earlier years, Selling, General & Administrative came in at $22.87 billion in FY2024 (+6.3%), $21.51 billion in FY2023 (+6.3%), $20.25 billion in FY2022 and $22.08 billion in FY2021.
  • Quarterly Selling, General & Administrative has ranged from $2.74 billion in Q4 2022 to $6.75 billion in Q4 2025 over the past five years.
  • On a year-over-year basis, Selling, General & Administrative has increased for five consecutive quarters, with growth averaging 6.7% over the last eight quarters.
  • Peak year-over-year performance for Selling, General & Administrative in the last five years was growth of 112.0% in Q4 2023, against a decline of 2.8% in Q1 2025 at the low end.
  • Per Business Quant, the preceding three quarters came in at $6.03 billion (Q1 2026), $6.75 billion (Q4 2025) and $5.92 billion (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) SG&A (Qtr)
1 Eli Lilly 1,109.58 Bn 1,078.16 Bn 19.71 Bn 3.43 Bn
2 Johnson & Johnson 630.16 Bn 548.69 Bn 17.26 Bn 6.43 Bn
3 AbbVie 488.57 Bn 461.73 Bn 12.70 Bn 3.63 Bn
4 Merck 359.15 Bn 313.58 Bn 12.21 Bn 2.90 Bn
5 Novartis Ag 274.32 Bn 238.71 Bn 11.24 Bn -3.24 Bn
6 Astrazeneca 246.73 Bn 220.50 Bn 12.86 Bn -5.65 Bn
7 Amgen 224.28 Bn 179.68 Bn 7.24 Bn 1.75 Bn
8 Gilead Sciences 187.60 Bn 161.71 Bn 6.22 Bn 1.92 Bn
9 Pfizer 161.13 Bn 108.08 Bn 10.94 Bn 3.41 Bn
10 Vertex Pharmaceuticals 129.23 Bn 101.23 Bn 2.84 Bn 582.20 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 28, 2026 6.43 Bn
Mar 29, 2026 6.03 Bn
Dec 28, 2025 6.75 Bn
Sep 28, 2025 5.92 Bn
Jun 29, 2025 5.89 Bn
Mar 30, 2025 5.11 Bn
Dec 29, 2024 6.45 Bn
Sep 29, 2024 5.48 Bn
Jun 30, 2024 5.68 Bn
Mar 31, 2024 5.26 Bn
Dec 31, 2023 5.81 Bn
Oct 1, 2023 5.40 Bn
Jul 2, 2023 5.40 Bn
Apr 2, 2023 4.91 Bn
Jan 1, 2023 2.74 Bn
Oct 2, 2022 4.98 Bn
Jul 3, 2022 6.23 Bn
Apr 3, 2022 5.94 Bn
Oct 3, 2021 6.00 Bn
Jul 4, 2021 6.07 Bn
API Access

Johnson & Johnson Selling, General & Administrative API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=selling-general-and-administrative&ticker=JNJ&period=max&api_key=YOUR_API_KEY